[1]
Kashif Khalid, “‘EVALUATING ANTIDIABETIC DRUG THERAPIES IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME: BIOCHEMICAL IMPACT AND CARDIOVASCULAR BENEFITS OF SGLT2 INHIBITORS - A CROSS-SECTIONAL STUDY’”, J Popl Ther Clin Pharmacol, vol. 32, no. 9, pp. 1464–1471, Oct. 2025, doi: 10.53555/mzmf6t81.